Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for ICU sleep promotion
ACTRN12624000991516Phase 2Completed
- Sponsor
- South Metropolitan Health Service
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in sleep deprivation and delirium comparing Dexmedetomidine plus sleep promotion bundle with Placebo plus sleep promotion bundle (2 arms). Primary endpoint: Difference in mean sleep quality score. Started Feb 2025; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
sleep deprivationdelirium
Beyond the preview
Go deeper on ACTRN12624000991516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624000991516.